Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03174314 · ClinicalTrials.gov registry record · NA

Feasibility and Efficacy of Assisstive Tactile and Auditory Communicating Devices

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
120
Enrollment target

NCT03174314 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 120 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03174314, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target

Study Summary

This pilot study will integrate multi-sensor fusion techniques (software) to effectively combine information obtained from the newly embedded infrared, ultrasound, and stereo-camera-based sensor systems (hardware) that are implemented into the VIS4ION platform. The core of this technology is based on 4 components: (1) a wearable vest with several distinct range and image sensors embedded. These sensors extract pertinent information about obstacles and the environment, which are conveyed to (2) a haptic interface (belt) that communicates this spatial information to the end-user in real-time via an intuitive, ergonomic and personalized vibrotactile re-display along the torso. (3) A smartphone serves as a connectivity gateway and coordinates the core components through WiFi, bluetooth, and/or 4G LTE, (4) a headset that contains both binaural, open-ear, bone conduction speakers (leaving the ear canal patent for ambient sounds) and a microphone for oral communication-based voice recognition during use of a virtual personal assistant (VPA). Blindfolded-sighted, and blind subjects in a real-world, combined obstacle avoidance / navigation task will serve as an independent measure of overall improvements in the system as well as a roadmap for future avenues to enhance performance. Further, a prospective, randomized crossover, controlled, non-blinded phase will be conducted in Thailand as part of this study to compare and evaluate effectiveness of the wearable vest for increasing navigation and quality of life.

Interventions

  • BEHAVIORAL Standard object battery and training sequence
  • DEVICE VIS4ION System

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2017-07-26
Est. Completion 2024-07-23
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT03174314

The ClinicalTrials.gov registry entry for NCT03174314 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Standard object battery and training sequence is the first listed.

NCT03174314 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03174314 about?

NCT03174314 is a clinical study titled "Feasibility and Efficacy of Assisstive Tactile and Auditory Communicating Devices". This pilot study will integrate multi-sensor fusion techniques (software) to effectively combine information obtained from the newly embedded infrared, ultrasound, and stereo-camera-based sensor systems (hardware) that are implemented into the VIS4ION platform. The core of this technology is based ...

What is the current status of trial NCT03174314?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2017-07-26. Estimated completion is 2024-07-23.

What interventions are being tested in trial NCT03174314?

The interventions under investigation include: Standard object battery and training sequence (BEHAVIORAL), VIS4ION System (DEVICE).

Who is sponsoring clinical trial NCT03174314?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.